Other
Virtual Reality
0
Pipeline Programs↗
10
Active Trials↗
1
Companies Involved↗
Virtual Reality is an early-stage landscape with 0 programs across 1 company. The most active players are Thoalfokar Mohammed Al-Obaidi.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
29
clinical trials
Completed8 · 28%
Unknown status6 · 21%
Not yet recruiting5 · 17%
Recruiting5 · 17%
Withdrawn5 · 17%
Clinical Trials
Trial Activity
29 trials
The Effectiveness of Immersive Virtual Reality as a Pain Control Modality After Hip Arthroscopy
Recruiting·—·N/A·NCT05868369·70 enrolled
METHOXYFLURANE or Virtual Reality Headset vs Standard Analgesic Management for the Reduction of Anterior Shoulder Dislocation (HYPNOLUX)
Recruiting·—·Phase 4·NCT05821517·150 enrolled
Effect of Virtual Reality on Depression in Adolescent Females
Not yet recruiting·—·N/A·NCT07452341·48 enrolled
Effect of Virtual Reality Guided Imagery on Pain, Anxiety, and Fatigue in Cancer Patients Undergoing Chemotherapy: A Randomized Controlled Trial
Not yet recruiting·—·Preclinical·NCT07677436·108 enrolled
The Use of Virtual Reality and Music Therapy for Hypertensive Urgency
Completed·—·N/A·NCT07272486·130 enrolled
Virtual Reality Compared to Nitrous Oxide for Labor Analgesia
Completed·—·N/A·NCT04749043·20 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)